Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

BACKGROUND: Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage of heparin. All patients referre...

Descripción completa

Detalles Bibliográficos
Autores principales: Helms, Julie, Severac, François, Merdji, Hamid, Schenck, Maleka, Clere-Jehl, Raphaël, Baldacini, Mathieu, Ohana, Mickaël, Grunebaum, Lélia, Castelain, Vincent, Anglés-Cano, Eduardo, Sattler, Laurent, Meziani, Ferhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829649/
https://www.ncbi.nlm.nih.gov/pubmed/33492445
http://dx.doi.org/10.1186/s13613-021-00809-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829649/
https://www.ncbi.nlm.nih.gov/pubmed/33492445
http://dx.doi.org/10.1186/s13613-021-00809-5

Ejemplares similares